Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:2587-2593
Published online before print May 10, 2004, doi: 10.1161/01.CIR.0000129768.35536.FA
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/21/2587    most recent
01.CIR.0000129768.35536.FAv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iaccarino, G.
Right arrow Articles by Trimarco, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iaccarino, G.
Right arrow Articles by Trimarco, B.
Related Collections
Right arrow Animal models of human disease
Right arrow Cell signalling/signal transduction
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 2004;109:2587-2593.)
© 2004 American Heart Association, Inc.


Basic Science Reports

AKT Participates in Endothelial Dysfunction in Hypertension

Guido Iaccarino, MD, PhD; Michele Ciccarelli, MD; Daniela Sorriento, BS; Ersilia Cipolletta, MD; Vincenzo Cerullo, BS; Gianni Luigi Iovino, MD; Alessandro Paudice, MD; Andrea Elia, MD; Gaetano Santulli, MS; Alfonso Campanile, MS; Oreste Arcucci, MD; Lucio Pastore, MD, PhD; Francesco Salvatore, MD, PhD; Gianluigi Condorelli, MD, PhD; Bruno Trimarco, MD

From the Departments of Clinical Medicine, Cardiovascular and Immunological Sciences (G.I., M.C., D.S., E.C., G.L.I., A.P., A.E., G.S., A.C., O.A., B.T.), and Biochemistry and Medical Biotechnology (V.C., L.P., F.S.), and School of Biotechnologican Sciences (L.P., F.S.), University of Naples Federico II, Italy; CEINGE-Biotecnologie Avanzate, Naples (L.P., F.S.); and San Raffaele Biomedical Science Park of Rome (G.C.), Italy.

Correspondence to Guido Iaccarino, MD, PhD, Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Federico II University, Via Pansini 5, Edificio 2, 80131 Naples, Italy. E-mail guiaccar{at}unina.it

Received August 11, 2003; de novo received December 12, 2003; accepted February 11, 2004.

Background— In hypertension, reduced nitric oxide production and blunted endothelial vasorelaxation are observed. It was recently reported that AKT phosphorylates and activates endothelial nitric oxide synthase and that impaired kinase activity may be involved in endothelial dysfunction.

Methods and Results— To identify the physiological role of the kinase in normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR), we used adenoviral vectors to transfer the human AKT1 gene selectively to the common carotid endothelium. In vitro, endothelial vasorelaxations to acetylcholine, isoproterenol, and insulin were blunted in control carotids from SHR compared with WKY rats, and human AKT1 overexpression corrected these responses. Similarly, blood flow assessed in vivo by Doppler ultrasound was reduced in SHR compared with WKY carotids and normalized after AKT1 gene transfer. In primary cultured endothelial cells, we evaluated AKT phosphorylation, activity, and compartmentalization and observed a mislocalization of the kinase in SHR.

Conclusions— We conclude that AKT participates in the settings of endothelial dysfunction in SHR rats by impaired membrane localization. Our data suggest that AKT is involved in endothelium dysfunction in hypertension.


Key Words: endothelium • gene therapy • hypertension • signal transduction




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. G. Denniss and J. W. E. Rush
Impaired hemodynamics and endothelial vasomotor function via endoperoxide-mediated vasoconstriction in the carotid artery of spontaneously hypertensive rats
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1038 - H1047.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Angelone, A. M. Quintieri, B. K. Brar, P. T. Limchaiyawat, B. Tota, S. K. Mahata, and M. C. Cerra
The Antihypertensive Chromogranin A Peptide Catestatin Acts as a Novel Endocrine/Paracrine Modulator of Cardiac Inotropism and Lusitropism
Endocrinology, October 1, 2008; 149(10): 4780 - 4793.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. Iaccarino, M. Ciccarelli, D. Sorriento, G. Galasso, A. Campanile, G. Santulli, E. Cipolletta, V. Cerullo, V. Cimini, G. G. Altobelli, et al.
Ischemic Neoangiogenesis Enhanced by {beta}2-Adrenergic Receptor Overexpression: A Novel Role for the Endothelial Adrenergic System
Circ. Res., November 25, 2005; 97(11): 1182 - 1189.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. A. Potenza, F. L. Marasciulo, D. M. Chieppa, G. S. Brigiani, G. Formoso, M. J. Quon, and M. Montagnani
Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H813 - H822.
[Abstract] [Full Text] [PDF]